Shuxuetong Injection

DRUG2 trials

Sponsors

Beijing Tiantan Hospital, Dongzhimen Hospital, Beijing

Conditions

Embolic StrokeIschemic Stroke, Acute

Phase 4

Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism

CompletedNCT03090113

Beijing Tiantan HospitalEmbolic Stroke

Start: 2017-05-12End: 2019-06-21Updated: 2020-07-22

Unknown Phase

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

CompletedNCT06018181

Dongzhimen Hospital, BeijingIschemic Stroke, Acute

Start: 2023-09-28End: 2025-09-03Updated: 2026-02-27

Related Papers

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design

Stroke and Vascular Neurology2020-02-2712 citations